Twist Bioscience Corporation
Twist Bioscience Corporation, a leader in the Pharmaceutical Preparation Manufacturing industry, is headquartered in the United States. Founded in 2013, the company has rapidly established itself as a pioneer in synthetic DNA production, catering to diverse sectors including biotechnology, pharmaceuticals, and agriculture.
Twist Bioscience's innovative approach to DNA synthesis allows for high-throughput, cost-effective solutions that are unique in the market. Their core products include synthetic genes, gene fragments, and other DNA-based tools, which are essential for research and development in various scientific fields.
With a strong market position, Twist Bioscience has achieved significant milestones, including partnerships with major pharmaceutical companies and advancements in gene therapy applications. Their commitment to quality and efficiency continues to drive their success in the rapidly evolving biotechnology landscape.
-15 vs industry average
Twist Bioscience Corporation’s score of 23 is lower than 37% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Twist Bioscience Corporation?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Twist Bioscience Corporation's reported carbon emissions
Twist Bioscience Corporation, a US-based company operating in the Pharmaceutical Preparation Manufacturing industry, reported approximately 3,007,000 kg CO2e in total emissions for the year 2024. This figure encompasses Scope 1 and Scope 2 emissions, totalling approximately 7,000 kg CO2e and 3,000,000 kg CO2e respectively. Scope 3 emissions data for this period was not disclosed. The company has made a "Committed" near-term target for emissions reduction, as indicated by their Science Based Targets initiative (SBTi) commitment status dated 23 October 2025. Specific details regarding the classification and target year for their near-term or long-term reduction goals, including net-zero commitments, are not yet available. In terms of emission intensity, Twist Bioscience has provided production emission factors, noting that it takes approximately 28,400 kg CO2e per oligo panel. This metric helps in understanding the carbon footprint associated with their core production activities.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Twist Bioscience Corporation’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Twist Bioscience Corporation yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Twist Bioscience Corporation
Frequently asked questions
Common questions about Twist Bioscience Corporation’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project